Clifford Chance has advised Yisheng Biopharma Co., Ltd. on the deal, while Sidley Austin LLP and Maples and Calder advised R-Bridge Healthcare Fund.Yisheng Biopharma Co., Ltd….
This content is for Standard 1 Year members only. LoginJoin Now
Author: Giulia Di Palma
…
This content is for Standard 1 Year members only. LoginJoin Now